» Articles » PMID: 36970568

Mortality Patterns Among COVID-19 Patients in Two Saudi Hospitals: Demographics, Etiology, and Treatment

Overview
Publisher Wiley
Specialty Microbiology
Date 2023 Mar 27
PMID 36970568
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Saudi Arabia (SA) reported its first case of COVID-19 on 2 March 2020. Mortality varied nationwide; by April 14, 2020, Medina had 16% of SA's total COVID-19 cases and 40% of all COVID-19 deaths. A team of epidemiologists investigated to identify factors impacting survival.

Methods: We reviewed medical records from two hospitals: Hospital A in Medina and Hospital B in Dammam. All patients with a registered COVID-related death between March and May 1, 2020, were included. We collected data on demographics, chronic health conditions, clinical presentation, and treatment. We analyzed data using SPSS.

Results: We identified 76 cases: 38 cases from each hospital. More fatalities were among non-Saudis at Hospital A (89%) versus Hospital B (82%,  < 0.001). Hypertension prevalence was higher among cases at Hospital B (42%) versus Hospital A (21%) ( < 0.05). We found statistically significant differences ( < 0.05) in symptoms at initial presentation among cases at Hospital B versus Hospital A, including body temperature (38°C vs. 37°C), heart rate (104 bpm vs. 89 bpm), and regular breathing rhythms (61% vs. 55%). Fewer cases (50%) at Hospital A received heparin versus Hospital B (97%, -value < 0.001).

Conclusion: Patients who died typically presented with more severe illnesses and were more likely to have underlying health conditions. Migrant workers may be at increased risk due to poorer baseline health and reluctance to seek care. This highlights the importance of cross-cultural outreach to prevent deaths. Health education efforts should be multilingual and accommodate all literacy levels.

Citing Articles

Effect of the COVID-19 Pandemic on the Performance of Undergraduate Healthcare Students During Their Internship in Saudi Arabia.

Al Nufaiei Z, Omar H, Alghamdi R, Felemban S, Al Zhranei R, Alsulami M Adv Med Educ Pract. 2024; 15:695-706.

PMID: 39050117 PMC: 11268758. DOI: 10.2147/AMEP.S464750.


Repurposing surgical wards in pandemics - An appraisal of outcomes of COVID-19 patients treated in Orthopaedic wards.

Behera P, Ahmad Z, Dubepuria A, Mishra N, Chatterjee A, Santoshi J J Family Med Prim Care. 2024; 13(5):1868-1874.

PMID: 38948591 PMC: 11213389. DOI: 10.4103/jfmpc.jfmpc_1210_23.


Mortality patterns among COVID-19 patients in two Saudi hospitals: Demographics, etiology, and treatment.

AlGhawi F, Almudarra S, Assiri A Influenza Other Respir Viruses. 2023; 17(3):e13127.

PMID: 36970568 PMC: 10030359. DOI: 10.1111/irv.13127.

References
1.
Lipsitch M, Swerdlow D, Finelli L . Defining the Epidemiology of Covid-19 - Studies Needed. N Engl J Med. 2020; 382(13):1194-1196. DOI: 10.1056/NEJMp2002125. View

2.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

3.
Xu X, Wu X, Jiang X, Xu K, Ying L, Ma C . Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368:m606. PMC: 7224340. DOI: 10.1136/bmj.m606. View

4.
Scalinci S, Battagliola E . Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases. 2020; 20:e00774. PMC: 7195291. DOI: 10.1016/j.idcr.2020.e00774. View

5.
Qiu P, Zhou Y, Wang F, Wang H, Zhang M, Pan X . Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clin Exp Res. 2020; 32(9):1869-1878. PMC: 7391922. DOI: 10.1007/s40520-020-01664-3. View